(2R,3S,4R,5S)-2,3,4,5-Tetrahydroxyhexanedioic acid, 95.0%, 250g

(S)-TERT-BUTYL 3-AMINO-3-METHYLPYRROLIDINE-1-CARBOXYLATE, 95.0%, 100mg

4-Fluoro-2-(trifluoromethyl)benzoic Acid>97.0%(GC)(T)1g

6-(4-Methoxyphenyl)-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidine, 97.0%, 250mg

1,2,3,4-Tetrahydroisoquinoline-1-carboxylic acid hydrochloride, 97.0%, 10g

1,4-DIAZEPAN-6-ONE 2HCL, 95.0%, 1g

Columna capilar GC ROTI®Cap-5 MS Ultra, 25 m, 0,32 mm, 1,00 µm, 1 Pieza(s)

Dimethyl 6,6'-dimethyl-[2,2'-bipyridine]-4,4'-dicarboxylate, 95.0%, 10g

1-(tert-Butoxycarbonyl)-4-(1H-pyrazol-1-yl)piperidine-4-carboxylic acid, 95%, 250mg

3-(2,3-Dihydro-benzo[1,4]dioxine-6-sulfonylamino)-propionic acid, 95.0%, 500mg

Conjunto de contraste de fases Zernike PLPH 10/20/40/100 posición de campo claro y campo oscuro

5-Acetyl-2-amino-4-methyl-thiophene-3-carboxylic acid methyl ester, 95.0%, 500mg

(S)-tert-Butyl 2-amino-4-phenylbutanoate hydrochloride, 95.0%, 250mg